Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 1
1998 2
2000 4
2002 1
2003 3
2004 2
2005 2
2006 4
2007 4
2008 6
2009 5
2010 24
2011 27
2012 35
2013 28
2014 31
2015 29
2016 39
2017 34
2018 43
2019 41
2020 39
2021 22
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

371 results
Results by year
Filters applied: . Clear all
Page 1
Uterine fibroid management: from the present to the future.
Donnez J, Dolmans MM. Donnez J, et al. Hum Reprod Update. 2016 Nov;22(6):665-686. doi: 10.1093/humupd/dmw023. Epub 2016 Jul 27. Hum Reprod Update. 2016. PMID: 27466209 Free PMC article. Review.
The economic impact of uterine fibroid management is significant and it is imperative that new treatments be developed to provide alternatives to surgical intervention.There is growing evidence of the crucial role of progesterone pathways in the pathophysiology of uterine fibroid …
The economic impact of uterine fibroid management is significant and it is imperative that new treatments be developed to provide alternativ …
[Pharmacovigilance update].
Ekobena P, Ivanyuk A, Livio F. Ekobena P, et al. Rev Med Suisse. 2021 Jan 13;17(720-1):80-84. Rev Med Suisse. 2021. PMID: 33443836 Review. French.
Ranitidine: global market withdrawal due to contamination with nitrosamines. Ulipristal for uterine fibroids : market withdrawal due to risk of severe liver injury. ...
Ranitidine: global market withdrawal due to contamination with nitrosamines. Ulipristal for uterine fibroids : market withdrawal due …
Emergency Contraception.
Upadhya KK; COMMITTEE ON ADOLESCENCE. Upadhya KK, et al. Pediatrics. 2019 Dec;144(6):e20193149. doi: 10.1542/peds.2019-3149. Epub 2019 Nov 18. Pediatrics. 2019. PMID: 31740497 Review.
Emergency contraceptive methods include oral medications labeled and dedicated for use as EC by the US Food and Drug Administration (ulipristal and levonorgestrel), the "off-label" use of combined oral contraceptives, and insertion of a copper intrauterine device. ...
Emergency contraceptive methods include oral medications labeled and dedicated for use as EC by the US Food and Drug Administration (ulip …
Emergency Contraception.
Batur P, Kransdorf LN, Casey PM. Batur P, et al. Mayo Clin Proc. 2016 Jun;91(6):802-7. doi: 10.1016/j.mayocp.2016.02.018. Mayo Clin Proc. 2016. PMID: 27261868 Free article. Review.
There are 4 approved EC options in the United States. Although ulipristal acetate requires a provider's prescription, oral levonorgestrel (LNG) is available over the counter for women of all ages. ...Women who weigh more than 75 kg or have a body mass index greater than 25 …
There are 4 approved EC options in the United States. Although ulipristal acetate requires a provider's prescription, oral levonorges …
Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.
Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, Gainer E. Glasier AF, et al. Lancet. 2010 Feb 13;375(9714):555-62. doi: 10.1016/S0140-6736(10)60101-8. Epub 2010 Jan 29. Lancet. 2010. PMID: 20116841 Clinical Trial.
FINDINGS: In the efficacy-evaluable population, 1696 women received emergency contraception within 72 h of sexual intercourse (ulipristal acetate, n=844; levonorgestrel, n=852). There were 15 pregnancies in the ulipristal acetate group (1.8%, 95% CI 1.0-3.0) and 22 …
FINDINGS: In the efficacy-evaluable population, 1696 women received emergency contraception within 72 h of sexual intercourse (ulipristal …
Choice of contraceptives.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2018 Oct 8;60(1557):161-168. Med Lett Drugs Ther. 2018. PMID: 30335731 No abstract available.
Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A, Puscasiu L, Vollenhoven B. Lethaby A, et al. Cochrane Database Syst Rev. 2017 Nov 15;11(11):CD000547. doi: 10.1002/14651858.CD000547.pub2. Cochrane Database Syst Rev. 2017. PMID: 29139105 Free PMC article. Review.
GnRHa versus other medical therapies GnRHa was associated with a greater reduction in uterine volume (-47% with GnRHa compared to -20% and -22% with 5 mg and 10 mg ulipristal acetate) but was more likely to cause hot flushes (OR 12.3, 95% CI 4.04 to 37.48; 5 studies; 183 p …
GnRHa versus other medical therapies GnRHa was associated with a greater reduction in uterine volume (-47% with GnRHa compared to -20% and - …
Risk-efficacy balance of ulipristal acetate compared to surgical alternatives.
Middelkoop MA, Bet PM, Drenth JPH, Huirne JAF, Hehenkamp WJK. Middelkoop MA, et al. Br J Clin Pharmacol. 2021 Jul;87(7):2685-2697. doi: 10.1111/bcp.14708. Epub 2021 Jan 14. Br J Clin Pharmacol. 2021. PMID: 33341097 Free PMC article. Review.
METHODS: This overview will discuss the risk-benefit balance between ulipristal and DILI, describe the safety-efficacy balance of ulipristal and its alternative treatments and the arguments that led to the suspension of its marketing authorization. RESULTS: Ulipr …
METHODS: This overview will discuss the risk-benefit balance between ulipristal and DILI, describe the safety-efficacy balance of …
Update on emergency contraception.
Fok WK, Blumenthal PD. Fok WK, et al. Curr Opin Obstet Gynecol. 2016 Dec;28(6):522-529. doi: 10.1097/GCO.0000000000000320. Curr Opin Obstet Gynecol. 2016. PMID: 27676405 Review.
The maximum achieved serum concentration of levonorgestrel (LNG) is lower in obese women than women of normal BMI, and doubling the dose of LNG (3 mg) increases its concentration maximum, approximating the level in normal BMI women receiving one dose of LNG. Repeated use of both …
The maximum achieved serum concentration of levonorgestrel (LNG) is lower in obese women than women of normal BMI, and doubling the dose of …
Limbo.
Schorge JO. Schorge JO. Obstet Gynecol. 2018 Jun;131(6):959-960. doi: 10.1097/AOG.0000000000002610. Obstet Gynecol. 2018. PMID: 29688918 No abstract available.
371 results